| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrative Physiology/Experimental Medicine |
From the Division of Endocrinology, University of Utah School of Medicine, Salt Lake City, Utah.
Correspondence to Dr Donald McClain, Division of Endocrinology, University of Utah, Salt Lake City, UT 84132. E-mail donald.mcclain{at}hsc.utah.edu
Objective— Glucose flux through the hexosamine biosynthesis pathway (HBP) has been implicated in the development of diabetic vascular complications. O-linked N-acetylglucosamine (O-GlcNAc) modification on protein is the major mechanism mediating the actions of the HBP. Impaired angiogenesis is well-recognized in diabetes; however, the mechanisms are not completely defined. Here, we investigated the role of protein O-GlcNAc modification in angiogenesis.
Methods and Results— In a mouse aortic ring assay, elevated O-GlcNAc levels induced by high-fat diet, streptozotocin-induced diabetes, or in vitro glucosamine treatment were associated with impaired angiogenesis. In cultured human umbilical vein endothelial cells and EA.hy926 endothelial cells, glucosamine increased protein O-GlcNAc modification and inhibited cell migration and capillary-like structure formation. Conversely, removal of O-GlcNAc by adenoviral-mediated overexpression of O-GlcNAcase improved these steps of angiogenesis. Also, high concentrations of glucose reduced capillary-like structure formation of human umbilical vein endothelial cells. Akt was recognized by an O-GlcNAc specific lectin, and glucosamine increased the amounts of Akt protein in these lectin precipitates. Increased glycosylation paralleled reduced Akt activity in endothelial cells.
Conclusion— These results suggest that elevated protein O-GlcNAc modification through the HBP impairs angiogenesis in endothelial cells, possibly by inhibiting Akt signaling.
Angiogenesis is impaired in diabetes. Here, we demonstrate that elevated O-GlcNAc levels inhibit vascular sprouting from mouse aortic rings and migration and capillary-like structure formation of endothelial cells. Akt signaling plays a key role in this O-GlcNAc–mediated angiogenesis regulation.
Key Words: hexosamine angiogenesis O-GlcNAc endothelial cells Akt
Related Article:
Arterioscler Thromb Vasc Biol 2008 28: 608-610.
This article has been cited by other articles:
![]() |
D. R. D'Souza, M. M. Salib, J. Bennett, M. Mochin-Peters, K. Asrani, S. E. Goldblum, K. J. Renoud, P. Shapiro, and A. Passaniti Hyperglycemia Regulates RUNX2 Activation and Cellular Wound Healing through the Aldose Reductase Polyol Pathway J. Biol. Chem., July 3, 2009; 284(27): 17947 - 17955. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Laczy, B. G. Hill, K. Wang, A. J. Paterson, C. R. White, D. Xing, Y.-F. Chen, V. Darley-Usmar, S. Oparil, and J. C. Chatham Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H13 - H28. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Ngoh and S. P. Jones New Insights into Metabolic Signaling and Cell Survival: The Role of {beta}-O-Linkage of N-Acetylglucosamine J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 602 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. Soesanto, B. Luo, D. Jones, R. Taylor, J. S. Gabrielsen, G. Parker, and D. A. McClain Regulation of Akt signaling by O-GlcNAc in euglycemia Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E974 - E980. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rask-Madsen and G. L. King More Sugar, Less Blood Vessels: Another Piece in the Puzzle of Increased Cardiovascular Risk in Diabetes Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 608 - 610. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |